Table 4.
Covariates | Hazard ratio | 95% confidence interval | P value |
---|---|---|---|
Age | 1.06 | (1.04–1.07) | <0.001 |
Townsend | |||
1 | 1.00 | (Reference level) | |
2 | 1.26 | (0.83–1.89) | 0.27 |
3 | 1.41 | (0.95–2.08) | 0.08 |
4 | 1.58 | (1.07–2.33) | 0.02 |
5 | 1.67 | (1.10–2.53) | 0.02 |
Missing | 1.23 | (0.77–1.97) | 0.38 |
BMI category | |||
<25 kg/m2 | 1.00 | (Reference level) | |
25–29.99 kg/m2 | 3.01 | (1.60–5.69) | 0.001 |
≥30 kg/m2 | 12.50 | (7.24–21.58) | <0.001 |
Missing | 3.64 | (1.91–6.95) | <0.001 |
Diabetes or IGR* | 0.72 | (0.44–1.18) | 0.19 |
Hypothyroidism | 1.76 | (1.20–2.58) | 0.004 |
Anovulation | 1.33 | (1.05–1.69) | 0.02 |
Androgen excess features | |||
Hirsutism | 1.37 | (1.05–1.80) | 0.02 |
Acne | 0.85 | (0.61–1.19) | 0.35 |
Alopecia | 0.97 | (0.64–1.46) | 0.89 |
Metformin | 1.69 | (1.28–2.22) | <0.001 |
Antiandrogen drug | 0.77 | (0.57–1.05) | 0.10 |
*Impaired glucose response (includes impaired fasting glucose and impaired glucose tolerance). Values in boldface indicate statistical significance.